ʻO ka 86th China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Fair (API Kina no ka pōkole)

Mea hoʻonohonoho: Reed Sinopharm Exhibition Co., Ltd.

Ka manawa hōʻikeʻike: Mei 26-28, 2021

Wahi: China Import and Export Fair Complex (Guangzhou)

Pākē hōʻike: 60,000 square meters

Nā mea hōʻikeʻike: 1500+

Helu hoʻolohe: 60000+

mākou,ʻO Changzhou Pharmaceutiacl Factorynona ka Shanghai Pharma.,e hele maiʻO ia ʻo China Import and Export Fair Complex (Guangzhou)ma 10.2M15 no tHe 86th China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Fair (API Kina no ka pōkole)

I nā makahiki i hala iho nei, ua hoʻopuka koʻu ʻāina i nā ʻano kulekele e paipai a kākoʻo i ka hoʻomohala ʻana o ka ʻoihana biomedical.Ma kēia pōʻaiapili, ua hoʻomaka pū ka ʻoihana biopharmaceutical e komo i kahi pae o ka hoʻomohala wikiwiki, a ua hōʻike i ka ulu ikaika ʻana.I kēia manawa, ua hoʻomaka ka ulu ʻana o kāna mākeke ma mua o ke kūlana holoʻokoʻa o ka mākeke lāʻau lapaʻau.Wahi a ka hōʻike Frost & Sullivan, i ka makahiki 2019, ua hōʻea ka mākeke biopharmaceutical Kina i 317.2 biliona yuan.Me ka hoʻonui ʻana o ka hiki, ka ulu ʻana o ka poʻe maʻi a me ka hoʻonui ʻana i ka uhi ʻinikua olakino, manaʻo ʻia ka mākeke biopharmaceutical e hiki i 464.4 biliona yuan i 2021.

A laila, i ke alo o nā mākeke mākeke nui, he aha nā laina nui o ka hoʻopukapuka ʻana i ka ʻoihana biopharmaceutical pono e nānā i ka makahiki 2021?Wahi a ka ʻoihana, e pili ana i ka huki hou ʻana o ka ʻāpana lāʻau lapaʻau, ua ʻōlelo ʻia e hoʻolohe i nā laina waiwai nui ʻekolu ma lalo o ke ʻano maʻamau o ka hoʻonui ʻana i ka ʻoihana.:

一.ʻO nā ʻoihana hou kiʻekiʻe me ka hoʻokūkū honua

ʻO ka lāʻau lapaʻau he ʻoihana puka lā me ka hoʻomohala ikaika.Eia nō naʻe, ma lalo o ke kumu e komo ana ka ʻoihana lāʻau lapaʻau i ka hoʻomohala kiʻekiʻe a ke wikiwiki nei ka ʻoihana i kona hoʻololi ʻana, ʻo ka hoʻomohala ʻana i nā lāʻau lapaʻau hou e nā hui lāʻau lapaʻau ke kī i ka hoʻoponopono ʻana i nā pono lapaʻau i kūpono ʻole, hoʻomau a hoʻokūkū. 

I kēia manawa, mai kahi hiʻohiʻona honua, ʻo nā hui lāʻau lapaʻau nui nui nā hui lāʻau lapaʻau hou.ʻO kahi laʻana, ʻo ke kumukūʻai mākeke o Johnson & Johnson, nona ka lāʻau lapaʻau a me nā lako, ʻoi aku ka kiʻekiʻe e like me 374,5 biliona kālā ʻAmelika, a ʻoi aku ka nui o ka mākeke o nā hui lāʻau lapaʻau kiʻekiʻe e like me Roche a me Pfizer ma mua o 100 biliona kālā ʻAmelika;akā, ʻo Teva Pharmaceuticals, kekahi o nā hui lāʻau lapaʻau nui loa o ka honua, he $12.3 biliona wale nō ka waiwai o ka mākeke.Hiki ke ʻike ʻia ma luna aʻe ua lilo ka mea hou i mea hoʻoikaika ikaika no ka hoʻomohala maikaʻi ʻana o ka ʻoihana biomedical a me nā ʻoihana.

Pono e hoʻomaopopo ʻia inā makemake mākou e loaʻa nā mākeke hou aʻe, ʻaʻole lawa ka hilinaʻi ʻana i ka mākeke kūloko wale nō.Ma ke kaomi wale ʻana i nā lāʻau hoʻokūkū ma waena o nā ʻāina ʻē a me ke komo ʻana i ka hoʻokūkū ma ka mākeke honua me ka nui o nā wahi e hiki ai iā mākou ke loaʻa ka manawa e loaʻa ai nā hoʻihoʻi maikaʻi aʻe..No laila, ke manaʻoʻiʻo nei ka ʻoihana ʻoi aku ka nui o nā manawa hoʻomohala kiʻekiʻe me nā ʻoihana hoʻokūkū kiʻekiʻe.Manaʻo ʻia e hoʻolohe i nā hui lāʻau lapaʻau hou i hoʻokumu i nā ala kūʻai pololei ma waho.

二.ʻO ka ʻāpana waiwai e pili ana i DRGs

I ka makahiki 2021, e hoʻomaka ana ka uku maoli o nā DRG, kahi e loaʻa ai ka hopena koʻikoʻi i ka maʻi maʻi a me ka mālama ʻana, nā uku mālama inikua olakino, etc. ka hoʻohana ʻana i kekahi mau lāʻau kumu kūʻai nui, ʻoiai no nā lāʻau noiʻi kumu, e loaʻa i nā hui lāʻau kūpono ke pōʻino nui inā ʻaʻole lākou e hoʻololi i ka manawa.

Eia naʻe, ʻoiai ʻo kekahi mau lāʻau lapaʻau a me nā hui e hoʻokūkū nui ʻia.Eia nō naʻe, wānana ka ʻoihana ʻaʻole hiki ke hoʻopilikia ʻia nā ʻano lāʻau me nā ʻano hoʻohana ikaika, nā lāʻau ulia pōpilikia, ka mālama hope ʻana a me nā lāʻau lapaʻau ma waho, a ma lalo o ka loiloi kumukūʻai, e hāpai ia i ka piʻi ʻana o ka helu komo ICL a me ka lawe ʻana mai. hoʻololi i ka ʻoihana IVD.Eia kekahi, hiki ke pōmaikaʻi nā kumu waiwai o luna (nā lako a me nā lako, nā API patented) mai kēia.Manaʻo ʻia e hoʻolohe i: WuXi Biologics, Tofflon, Kailai Ying a me nā hui ʻē aʻe.

三.Highly prosperous lāʻau R&D outsourcing kahua

Ma lalo o ka mana o nā mea e like me ka piʻi holoʻokoʻa o ka hoʻopukapuka R&D lāʻau lapaʻau honua a me nā kulekele kūloko maikaʻi, ʻo ia ka ʻae ʻana i ka ʻoihana i ka mākeke lawelawe R&D outsourcing service (ie CXO), he ʻāpana koʻikoʻi o ke kaulahao ʻoihana lāʻau hou. maopopo ka pomaikai.

Manaʻo ka poʻe i loko o ka ʻoihana e lilo ana nā mea hoʻomaka i ka ikaika nui i ka noiʻi a me ka hoʻomohala ʻana i nā lāʻau lapaʻau hou i ka ʻoihana biomedical.Eia nō naʻe, ma muli o ka liʻiliʻi o nā talena, kālā, a me ka lewa, hoʻomaka ka hoʻomaka ʻana i nā limahana a ʻimi i ka hana kiʻekiʻe a me ke kumu kūʻai haʻahaʻa.No laila, hilinaʻi lākou i nā hui CXO.ʻOi aku ka kiʻekiʻe.Ua hoʻomaopopo ʻia ua ʻōlelo ʻia kahi hui CMO i hoʻopaʻa ʻia no nā kumu i luna nei, ua piʻi mālie ka hapa o nā hui lāʻau bio-innovative hoʻomaka i ka hana o nā hui CXO i nā makahiki i hala iho nei, a ke lilo nei hoʻi ia i kumu nui o ka haʻawina. i ka ulu ʻana o ka loaʻa kālā a me ka loaʻa kālā o ka hui CXO.